Latest tumor Stories
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, a professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine, has found that a protein involved in promoting tumor growth and survival is also activated in surrounding blood vessels, enabling cancer cells to spread into the bloodstream.
Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective.
Grant Program Addresses Three Critical Areas of Blood Cancer Research WHITE PLAINS, N.Y., Jan.
Cancer cells have something that every prisoner longs for—a master key that allows them to escape.
SAN FRANCISCO, Jan.
Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan.
Molecularly-Guided Therapies of Critical Importance for Rare Cancers with Fewer Treatment Options IRVING, Texas, Jan.
The Chris Elliott Fund, a 501(c)3 non-profit, held their grand opening on January 3rd.
Research uncovers clinically actionable biomarker targets and key treatment insights for colorectal, gastric, neuroendocrine and appendiceal cancer patients IRVING, Texas, Jan.
Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process.
- a meat pie that is usually eaten at Christmas in Quebec